Literature DB >> 18251740

Activation of Src-family tyrosine kinases in hyperproliferative epidermal disorders.

Elias E Ayli1, Weijie Li, Tamu T Brown, Agnieszka Witkiewicz, Rosalie Elenitsas, John T Seykora.   

Abstract

BACKGROUND: Src-family tyrosine kinases (SFKs) are important regulators of keratinocyte growth and differentiation. In a broad range of cell types, persistent activation of SFKs correlates with increased cell proliferation. In this study, we determined if SFK activity is increased in cutaneous neoplasia and psoriasis, common hyperproliferative epidermal disorders.
METHODS: Formalin-fixed tissue sections of unremarkable epidermis, psoriasis, actinic keratoses (AKs), squamous cell carcinoma in situ (SCIS) and squamous cell carcinoma (SCC) were subjected to immunohistochemical staining for activated SFKs.
RESULTS: All psoriasis specimens displayed significantly greater staining for activated SFKs than sections of unremarkable skin. In the psoriasis biopsies, the degree of epidermal hyperplasia was proportional to the level of activated SFK staining. All AKs, SCISs and SCCs exhibited more prominent staining than sections of unremarkable epidermis. No discernable difference in activated SFK staining was seen between AKs, SCIS and SCC specimens.
CONCLUSIONS: This study shows increased staining of activated SFKs in human biopsy specimens of psoriasis and cutaneous neoplasia. These data provide direct evidence for increased activation of SFKs in the pathogenesis of hyperproliferative epidermal disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18251740      PMCID: PMC3099403          DOI: 10.1111/j.1600-0560.2007.00807.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  10 in total

Review 1.  Src family tyrosine kinases and growth factor signaling.

Authors:  C L Abram; S A Courtneidge
Journal:  Exp Cell Res       Date:  2000-01-10       Impact factor: 3.905

Review 2.  Psoriasis.

Authors:  Michael P Schön; W-Henning Boehncke
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

3.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

4.  'Srcasm: a novel Src activating and signaling molecule.

Authors:  John T Seykora; Lijuan Mei; G Paolo Dotto; Paul L Stein
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

5.  Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.

Authors:  Weijie Li; Christine Marshall; Lijuan Mei; Joel Gelfand; John T Seykora
Journal:  J Biol Chem       Date:  2006-10-16       Impact factor: 5.157

Review 6.  Src family protein tyrosine kinases and cellular signal transduction pathways.

Authors:  T Erpel; S A Courtneidge
Journal:  Curr Opin Cell Biol       Date:  1995-04       Impact factor: 8.382

7.  Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.

Authors:  Rainer Zenz; Robert Eferl; Lukas Kenner; Lore Florin; Lars Hummerich; Denis Mehic; Harald Scheuch; Peter Angel; Erwin Tschachler; Erwin F Wagner
Journal:  Nature       Date:  2005-09-15       Impact factor: 49.962

Review 8.  Epidermal growth factor receptor: mechanisms of activation and signalling.

Authors:  Robert N Jorissen; Francesca Walker; Normand Pouliot; Thomas P J Garrett; Colin W Ward; Antony W Burgess
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

9.  Srcasm modulates EGF and Src-kinase signaling in keratinocytes.

Authors:  Weijie Li; Christine Marshall; Lijuan Mei; Leonard Dzubow; Chrysalene Schmults; Michael Dans; John Seykora
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

10.  fyn tyrosine kinase is involved in keratinocyte differentiation control.

Authors:  E Calautti; C Missero; P L Stein; R M Ezzell; G P Dotto
Journal:  Genes Dev       Date:  1995-09-15       Impact factor: 11.361

  10 in total
  20 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

2.  Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma.

Authors:  Xiaoping Yang; Aliaa E M Daifallah; Shiela Shankar; Jacob Beer; Christine Marshall; Tzvete Dentchev; Francesca Seykora; Sebastian D'Armas; Jaeyi Hahn; Vivian Lee; Hanan H Sabry; Assem M Farag; John T Seykora
Journal:  Exp Dermatol       Date:  2019-03-13       Impact factor: 3.960

3.  Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity.

Authors:  Kyung Mi Lee; Ki Won Lee; Sung Keun Jung; Eun Jung Lee; Yong-Seok Heo; Ann M Bode; Ronald A Lubet; Hyong Joo Lee; Zigang Dong
Journal:  Biochem Pharmacol       Date:  2010-07-01       Impact factor: 5.858

4.  Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration.

Authors:  Vipin Yadav; Mitchell F Denning
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

5.  Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK.

Authors:  Keitaro Yamane; Masatoshi Jinnin; Tomomi Etoh; Yuki Kobayashi; Naoki Shimozono; Satoshi Fukushima; Shinichi Masuguchi; Keishi Maruo; Yuji Inoue; Tsuyoshi Ishihara; Jun Aoi; Yuichi Oike; Hironobu Ihn
Journal:  J Mol Med (Berl)       Date:  2012-07-25       Impact factor: 4.599

Review 6.  From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma.

Authors:  Vladimir Ratushny; Michael D Gober; Ryan Hick; Todd W Ridky; John T Seykora
Journal:  J Clin Invest       Date:  2012-02-01       Impact factor: 14.808

7.  The DNA damage-binding protein XPC is a frequent target for inactivation in squamous cell carcinomas.

Authors:  Sebastien de Feraudy; Katie Ridd; Lauren M Richards; Pui-Yan Kwok; Ingrid Revet; Dennis Oh; Luzviminda Feeney; James E Cleaver
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

8.  Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress.

Authors:  Vivian Lee; Michael D Gober; Hasan Bashir; Conor O'Day; Ian A Blair; Clementina Mesaros; Liwei Weng; Andrew Huang; Aaron Chen; Rachel Tang; Vince Anagnos; JiLon Li; Sophie Roling; Emilija Sagaityte; Andrew Wang; Chenyan Lin; Christopher Yeh; Cem Atillasoy; Christine Marshall; Tzvete Dentchev; Todd Ridky; John T Seykora
Journal:  Exp Dermatol       Date:  2019-10-29       Impact factor: 3.960

9.  Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.

Authors:  Yu Qi; Xin Li; Liang Zhao; John T Seykora
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

10.  Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.

Authors:  Liang Zhao; Weijie Li; Christine Marshall; Thomas Griffin; Matthew Hanson; Ryan Hick; Tzvete Dentchev; Erik Williams; Adrienne Werth; Christopher Miller; Hasan Bashir; Warren Pear; John T Seykora
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.